BMS1P7

Across TCGA pan-cancer cohorts, BMS1P7 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated BMS1P7 data layer compared with 3 for mutation status.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher BMS1P7 RNA is associated with better overall survival. In most high-consensus cancer types, elevated BMS1P7 expression acts as an unfavorable survival marker, although some lineages such as BLCA and UCS show a favorable association.

BLCA, UCS, and CHOL are the cancer types where BMS1P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.547	0.364	<.001	152	view →
UCS	DFS	Median	IV	0.952	0.367	.001	54	view →
CHOL	DFS	Tertile	III,IV	0.031	0.505	.003	48	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	36	view →
STAD	OS	Median	III,IV	0.361	0.636	<.001	29	view →
KICH	OS	Quartile	II,III,IV	0.452	1.000	.010	25	view →
COAD	DFS	Tertile	II,III,IV	0.962	0.738	.006	24	view →
LIHC	OS	Tertile	II,III,IV	0.487	0.722	.012	15	view →
TGCT	DFS	Quartile	II,III,IV	0.586	1.000	.027	14	view →
KIRP	DFS	Median	All	0.800	0.930	.002	12	view →
THCA	DFS	Quartile	IV	0.397	0.737	.030	9	view →
SKCM	OS	Quartile	All	0.836	0.768	.020	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

BMS1P7–BLCA (OS)

Open the BLCA breakdown →